Inari Medical (NARI) Stock Forecast & Price Target

$49.48 -0.18 (-0.36%)

(As of 11/25/2024 ET)

Inari Medical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 11 Analyst Ratings

Sell
0

Hold
6

Buy
5

Based on 11 Wall Street analysts who have issued ratings for Inari Medical in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 6 have given a hold rating, and 5 have given a buy rating for NARI.

Consensus Price Target

$58.89
19.02% Upside

According to the 11 analysts' twelve-month price targets for Inari Medical, the average price target is $58.89. The highest price target for NARI is $74.00, while the lowest price target for NARI is $47.00. The average price target represents a forecasted upside of 19.02% from the current price of $49.48.

Get the Latest News and Ratings for NARI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Inari Medical and its competitors.

NARI Analyst Ratings Over Time

Type	Current Forecast 11/27/23 to 11/26/24	1 Month Ago 10/28/23 to 10/27/24	3 Months Ago 8/29/23 to 8/28/24	1 Year Ago 11/27/22 to 11/27/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	4 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	3 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$58.89	$57.44	$61.29	$82.00
Forecasted Upside	19.02% Upside	31.45% Upside	40.15% Upside	40.36% Upside
Consensus Rating	Hold	Hold	Moderate Buy	Moderate Buy

The Biggest Post-Election Market Shift Ever? (Ad)

Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.

Get our No. 1 stock (with 500%-plus upside potential) for this rare market event now.

NARI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NARI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Inari Medical Stock vs. The Competition

Type	Inari Medical	Medical Companies	S&P 500
Consensus Rating Score	2.45	2.80	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	19.02% Upside	17,640.62% Upside	6.38% Upside
News Sentiment Rating	Positive News See Recent NARI News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/29/2024	Truist Financial 2 of 5 stars		Boost Target	Hold ➝ Hold	$46.00 ➝ $50.00	+4.69%
10/29/2024	Canaccord Genuity Group 1 of 5 stars		Boost Target	Buy ➝ Buy	$71.00 ➝ $74.00	+73.87%
10/29/2024	Needham & Company LLC 3 of 5 stars	M. Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold
10/29/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$50.00 ➝ $52.00	+22.18%
10/29/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$66.00 ➝ $67.00	+57.42%
9/17/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$50.00	+13.38%
"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined" (Ad) What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about? Click here to see why experts and insiders may be preparing for the biggest financial crisis of the
9/3/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Kratky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
9/3/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform	$47.00	+8.72%
8/9/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$68.00	+39.57%
7/31/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$84.00 ➝ $65.00	+39.16%
7/25/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Kaczor Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
8/3/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$83.00	+28.15%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 02:17 AM ET.

NARI Forecast - Frequently Asked Questions

: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Inari Medical is $58.89, with a high forecast of $74.00 and a low forecast of $47.00.
: 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last twelve months. There are currently 6 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NARI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NARI, but not buy additional shares or sell existing shares.
: According to analysts, Inari Medical's stock has a predicted upside of 19.02% based on their 12-month stock forecasts.
: Over the previous 90 days, Inari Medical's stock had 1 upgrade by analysts.
: Inari Medical has been rated by research analysts at Canaccord Genuity Group, Leerink Partners, Leerink Partnrs, Needham & Company LLC, Piper Sandler, Robert W. Baird, Stifel Nicolaus, and Truist Financial in the past 90 days.
: Analysts like Inari Medical less than other "medical" companies. The consensus rating for Inari Medical is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how NARI compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Former Trump advisor issues urgent warning (Ad)

Elon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force will put millions of Americans out of work. The ripple effects could nudge the US economy into a catastrophic tailspin. If this happens, you need to be prepared. That’s why a former Trump advisor is sharing his contingency plan with the public. What is Musk talking about?

Get the full details now.

This page (NASDAQ:NARI) was last updated on 11/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inari Medical (NARI) Stock Forecast & Price Target